Bassil I. Dahiyat

Bassil I. Dahiyat

DirectoratXencor· In proxies 2021–2025

Pay in FY2025-19% from the year before · Xencor stock -33.4% the same year

Bassil I. Dahiyat was paid $5.5M in FY2025 (Dec), down 19%. Xencor stock fell 33.4% that year.

Pay$100 in the stock at the end of FY20 → $35
Pay is from the Summary Compensation Table of each Xencor proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Kodiak SciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. XencorPublic company · 5 yr
    • President, Chief Executive Officer and Director2021 – Present · 5 yrStock in role -35%
  3. Kodiak Sciences Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Terray Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Kodiak SciencesDirector · 7 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?